HENRY PFEIFER: Open Payments
NPI 1598478281 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,791 in 81 payments from 18 companies in 2025. Trend: 2023 $1,552 · 2024 $1,614 · 2025 $1,791
Food & beverage: $1,791
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $376 |
| Lundbeck LLC | 7 | $186 |
| Neurocrine BioSciences, Inc. | 7 | $161 |
| ABBVIE INC. | 15 | $160 |
| Otsuka America Pharmaceutical, Inc. | 7 | $147 |
| Janssen Pharmaceuticals, Inc | 6 | $120 |
| Teva Pharmaceuticals USA, Inc. | 5 | $105 |
| Axsome Therapeutics, Inc. | 5 | $99 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Collegium Pharmaceutical, Inc. | 3 | $64 |
Products named: REXULTI, VIVITROL, INGREZZA, VRAYLAR, ARISTADA, SPRAVATO, Auvelity, UZEDY.
Industry payments across NC — which companies pay providers there.
